Amicus Therapeutics, Inc. (FOLD) Technical Analysis
$14.28▲0.21%
Market is closed - opens 8 PM, 07 Jan 2026
Insights
- Amicus Therapeutics is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
- Based on analysis of the Oscillators technical indicator, the current market trend for Amicus Therapeutics stock suggests that it is a good time to sell or bad time to initiate a fresh position
- Based on analysis of the Moving Averages technical indicator, Amicus Therapeutics stock is in a uptrend ↗️
- Based on analysis of the Pivot Points, the current market trend for Amicus Therapeutics stock suggests that it is a good time to buy
Analysis Summary
Oscillators
Sell
Neutral
Buy
Moving Averages
Sell
Neutral
Buy
Pivots
Sell
Neutral
Buy
Oscillators
Name | Value | Action |
|---|---|---|
Relative Strength Index | 90.4 | Sell |
Stochastic | 97.15, 97.53 | Sell |
Ultimate Oscillator | 76.18 | Sell |
Stochastic Relative Strength Index | 97.45, 98.79 | Sell |
Moving Average Convergence Divergence | 1.25, 1.13 | Buy |
Moving Averages
Simple Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 14.24 | Buy |
20 | 12.29 | Buy |
50 | 10.52 | Buy |
Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 13.74 | Buy |
20 | 12.74 | Buy |
50 | 11.04 | Buy |
Volume Weighted Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 14.23 | Neutral |
20 | 13.62 | Neutral |
50 | 12.43 | Buy |
Double Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 14.72 | Buy |
20 | 14.37 | Buy |
50 | 12.9 | Buy |
Triple Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 14.64 | Sell |
20 | 14.92 | Buy |
50 | 13.82 | Buy |
Pivot
Pivot | Value |
|---|---|
Resistance L3 | 14.32 |
Resistance L2 | 14.3 |
Resistance L1 | 14.28 |
Pivot Point | 14.26 |
Support L1 | 14.24 |
Support L2 | 14.22 |
Support L3 | 14.2 |
*Disclaimer: The content present here is for informational purposes only, you should not construe any such information or other material as investment advisory.